The Global Oroxylin A Market was valued at USD 12.8 Million in 2023 and is projected to reach USD 21.5 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period (2024–2030). This robust growth trajectory is propelled by escalating research into natural flavonoids for therapeutic applications, increasing demand for herbal and nutraceutical products, and the compound’s promising efficacy in cancer research and neuroprotective therapies.

As the pharmaceutical and nutraceutical industries increasingly turn to nature-derived compounds for novel treatments, the focus sharpens on the key producers and suppliers ensuring the purity, quality, and availability of Oroxylin A. In this blog, we profile the Top 10 Companies in the Oroxylin A Industry—a group of specialized biotechnology firms, chemical suppliers, and research ingredient specialists shaping the future of this high-potent flavonoid.

---

🔟 1. BOC Sciences

Headquarters: Shirley, New York, USA
Key Offering: High-Purity Oroxylin A (≥98%, ≥95%), Research Grade Standards

BOC Sciences is a globally recognized supplier of fine chemicals and pharmaceutical intermediates, including high-purity Oroxylin A. The company serves pharmaceutical companies, academic research institutions, and biotech firms worldwide, providing critical materials for drug discovery and development.

Research & Development Initiatives:

• Continuous optimization of extraction and purification processes

• Supply of analytical standards for pharmacokinetic and metabolic studies

• Custom synthesis services for derivative compounds

Download FREE Sample Report:
Global Oroxylin A Market – View in Detailed Research Report

---

9️⃣ 2. Yunnan Xili Biotechnology

Headquarters: Kunming, Yunnan, China
Key Offering: Plant-extracted Oroxylin A, Scutellaria baicalensis Extracts

Yunnan Xili Biotechnology leverages its strategic location in a biodiversity hotspot to specialize in the extraction of bioactive compounds from traditional Chinese medicinal herbs. The company is a prominent supplier of Oroxylin A derived from the roots of Scutellaria baicalensis (Baical Skullcap).

Research & Development Initiatives:

• Sustainable sourcing of raw botanical materials

• Development of standardized extract formulations with guaranteed Oroxylin A content

---

8️⃣ 3. Chengdu Gleep Biotechnology

Headquarters: Chengdu, Sichuan, China
Key Offering: Oroxylin A (≥98% Purity), Natural Product APIs

Chengdu Gleep Biotechnology is a technology-driven enterprise focused on the research, development, and production of high-purity natural active ingredients. The company has established a robust supply chain for Oroxylin A, catering to the growing demand from the pharmaceutical and cosmetic industries.

Research & Development Initiatives:

• Investment in advanced chromatographic separation technologies

• Collaborations with academic institutions for pharmacological validation

---

7️⃣ 4. Shanghai Jiji Biochemical Technology

Headquarters: Shanghai, China
Key Offering: Biochemical Reagents, Oroxylin A Reference Standards

Shanghai Jiji Biochemical Technology supplies a wide array of biochemical reagents and reference standards to global research communities. The company’s high-quality Oroxylin A is essential for in-vitro and in-vivo studies exploring its anti-inflammatory and anticancer mechanisms.

Research & Development Initiatives:

• Rigorous quality control ensuring batch-to-batch consistency

• Development of metabolite standards for advanced research

---

6️⃣ 5. Shanghai Yuanye Biotechnology

Headquarters: Shanghai, China
Key Offering: Oroxylin A, Baicalein, Wogonin, and related flavonoids

Shanghai Yuanye Biotechnology is a leading manufacturer of plant-derived compounds and biochemicals. The company offers a comprehensive portfolio of skullcap-derived flavonoids, with Oroxylin A being a key product for research into its synergistic effects with other compounds.

Research & Development Initiatives:

• Expansion of product portfolio to include flavonoid mixtures and analogs

• Support for preclinical research with high-purity materials

Download FREE Sample Report:
Global Oroxylin A Market – View in Detailed Research Report

---

5️⃣ 6. Hubei Wanzhi Chemical Pharmaceutical

Headquarters: Wuhan, Hubei, China
Key Offering: Oroxylin A as a Pharmaceutical Intermediate

Hubei Wanzhi Chemical Pharmaceutical specializes in the scale-up production of chemical and pharmaceutical intermediates. The company’s focus on Oroxylin A is aligned with its strategy to supply building blocks for novel drug candidates, particularly in oncology and neurology.

Research & Development Initiatives:

• Process development for cost-effective, large-scale synthesis

• Exploration of Oroxylin A derivatives with improved bioavailability

---

4️⃣ 7. Sichuan Province Vikki Biotechnology

Headquarters: Chengdu, Sichuan, China
Key Offering: Natural Oroxylin A Extracts, Custom Extraction Services

Sichuan Province Vikki Biotechnology capitalizes on the rich botanical resources of Sichuan to produce high-quality plant extracts. The company provides Oroxylin A with a focus on natural and organic product manufacturers in the nutraceutical sector.

Research & Development Initiatives:

• Implementation of green extraction technologies

• Development of water-soluble formulations for enhanced application

---

3️⃣ 8. Jiangsu Yongjian Medical Technology

Headquarters: Taizhou, Jiangsu, China
Key Offering: Medical-Grade Oroxylin A, API Development

Jiangsu Yongjian Medical Technology is dedicated to the research and production of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is positioning Oroxylin A as a potential API for future therapeutic agents, adhering to strict Good Manufacturing Practice (GMP) standards.

Research & Development Initiatives:

• Stability and formulation studies for drug development

• Partnerships with drug developers for clinical trial material supply

---

2️⃣ 9. Cayman Chemical Company

Headquarters: Ann Arbor, Michigan, USA
Key Offering: High-Purity Oroxylin A for Research Use

While not listed in the initial segmentation, Cayman Chemical is a significant global player in the research chemicals market. The company supplies highly pure Oroxylin A to academic and industrial research laboratories for mechanistic studies and assay development, supported by comprehensive analytical data.

Research & Development Initiatives:

• Provision of well-characterized compounds for high-throughput screening

• Development of ELISA kits and antibodies for Oroxylin A detection

---

1️⃣ 10. TargetMol Chemicals

Headquarters: Boston, Massachusetts, USA
Key Offering: Oroxylin A as a Bioactive Screening Compound

TargetMol specializes in providing a vast library of natural products and inhibitors for drug discovery. Oroxylin A is featured in their catalog as a potent bioactive compound, primarily used by researchers screening for anti-cancer, anti-inflammatory, and neuroprotective agents.

Research & Development Initiatives:

• Integration of Oroxylin A into targeted screening libraries

• Generation of high-content screening data for customer validation

Get Full Report Here:
Global Oroxylin A Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Oroxylin A Is Rooted in Scientific Validation

The Oroxylin A market is transitioning from a niche research chemical to a compound with significant therapeutic potential. While current applications are predominantly research-focused, the industry is investing in clinical validation, advanced extraction technologies, and novel drug delivery systems to unlock its full commercial value.

📈 Key Trends Shaping the Market:

• Increasing number of preclinical studies validating anticancer and neuroprotective properties

• Growing consumer preference for natural and plant-based nutraceuticals

• Advancements in purification technologies ensuring higher yields and purity levels

• Strategic collaborations between ingredient suppliers and pharmaceutical companies for drug development

Get Full Report Here:
Global Oroxylin A Market – View in Detailed Research Report

The companies listed above are not only supplying a critical research compound—they are enabling the scientific exploration that could lead to the next generation of natural therapeutics.